Harris Williams & Co. Advises TrialCard on its Investment from Excellere Partners

January 16, 2015

Harris Williams & Co., a preeminent middle market investment bank focused on the advisory needs of clients worldwide, announces an investment in TrialCard Incorporated (TrialCard), a leading provider of patient access and adherence services to the pharmaceutical and biopharmaceutical industry, from Excellere Partners (Excellere). The transaction was led by Derek Lewis, James Clark, Paul Hepper and Taylor Morris of Harris Williams & Co.’s Richmond office and Sam Hendler of the firm’s Boston office.

“Dave Cunningham founded TrialCard in 2000, and today, the company is executing on his vision by addressing adherence, compliance and brand extension challenges with a comprehensive suite of innovative solutions that deliver attractive ROI for pharmaceutical marketers while also reducing overall healthcare costs through better patient outcomes,” said Derek Lewis, a managing director at Harris Williams & Co. “Excellere, whose senior leaders have completed nearly 50 healthcare transactions, is an experienced investor and will be an excellent partner as TrialCard’s management team executes on the next phase of the company’s strategic and growth objectives.”

“TrialCard is well positioned to build upon its history of leadership within the patient access and medication adherence market,” added Brad Cornell, principal at Excellere Partners. “Together, TrialCard’s senior management and the Excellere team will seek to enhance the value proposition that the company provides for customers through a combination of service optimization, organic growth initiatives and complementary acquisitions that further improve patient outcomes and drive attractive return on investments to clients.”

TrialCard is a leading provider of pharmaceutical marketing and customer support services. Headquartered in Cary, NC, TrialCard is the largest provider of patient access programs in the industry, processing over $1 billion in patient benefits per year to help brand manufacturers achieve their goals with prescribers, patients and pharmacists.

Excellere is a Denver-based private equity investment firm that currently manages $737 million of committed capital. The firm specializes in partnering with entrepreneurs and management teams through majority recapitalizations and management buyouts. Excellere employs a buy-and-build strategy that provides its portfolio companies with capital as well as a proprietary value creation process designed to accelerate growth while enhancing the company’s corporate foundation.

Harris Williams & Co. (www.harriswilliams.com), a member of The PNC Financial Services Group, Inc. (NYSE:PNC), is a preeminent middle market investment bank focused on the advisory needs of clients worldwide.  The firm has deep industry knowledge, global transaction expertise and an unwavering commitment to excellence.  Harris Williams & Co. provides sell-side and acquisition advisory, restructuring advisory, board advisory, private placements and capital markets advisory services.

Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which is authorized and regulated by the Financial Conduct Authority.  Harris Williams & Co. is a trade name under which Harris Williams LLC and Harris Williams & Co. Ltd conduct business.